Feedback / Questions
MAD-paclitaxel therapy - Navidea
MAD-bisphosphonate therapy - Navidea
https://www.businesswire.com/news/home/20221107005987/en/Navidea-Biopharmaceuticals-Announces-Details-of-Presentation-at-Upcoming-Society-for-Immunotherapy-of-Cancer-Annual-Meeting
Nov 7, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next